Treating Recurrent Tricuspid Regurgitation and Iatrogenic Atrial Septal Defect.
CAVI
transcutaneous tricuspid valve intervention
tricuspid regurgitation
valvular heart disease
Journal
JACC. Case reports
ISSN: 2666-0849
Titre abrégé: JACC Case Rep
Pays: Netherlands
ID NLM: 101757292
Informations de publication
Date de publication:
19 Apr 2023
19 Apr 2023
Historique:
received:
06
10
2022
revised:
12
01
2023
accepted:
26
01
2023
medline:
24
4
2023
pubmed:
24
4
2023
entrez:
24
04
2023
Statut:
epublish
Résumé
Heterotopic caval valve implantation may be a reasonable option for alleviating symptoms in select high-risk patients with recurrent tricuspid regurgitation after failed interventional tricuspid valve repair. However, altered right atrial hemodynamic status should be considered in procedural planning to avoid potential right-left shunting in cases of septal defects. (
Identifiants
pubmed: 37091059
doi: 10.1016/j.jaccas.2023.101775
pii: S2666-0849(23)00050-5
pmc: PMC10119479
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101775Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
Dr Mach has received institutional grants, research support, speaker honoraria, and travel compensation from Edwards Lifesciences, Symetis, JenaValve, Boston Scientific, Medtronic, Abbott, and Novartis. Dr Andreas is a proctor, consultant, and speaker for Edwards Lifesciences, Abbott, Medtronic, Boston Scientific, AbbVie, and Zoll; and has received institutional research grants from Edwards Lifesciences, Abbott, Medtronic, and LSI. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Références
J Clin Med. 2021 Oct 07;10(19):
pubmed: 34640619
Am J Cardiol. 2018 Feb 15;121(4):475-479
pubmed: 29268934
Ann Thorac Surg. 2022 Feb;113(2):585-592
pubmed: 33831392
J Card Surg. 2022 Jul;37(7):1959-1966
pubmed: 35385588
JACC Cardiovasc Interv. 2022 Jul 11;15(13):1366-1377
pubmed: 35583363
JACC Case Rep. 2022 Aug 17;4(16):1012-1014
pubmed: 36062053
Eur Heart J. 2022 Feb 12;43(7):654-662
pubmed: 34586392
JACC Cardiovasc Interv. 2021 Dec 27;14(24):2685-2694
pubmed: 34949392
Heart. 2019 Jun;105(11):864-872
pubmed: 30482796